The small island nation of Mauritius has become the first country in the world to prove it is reversing the type 2 diabetes epidemic, according to new research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan and published in The Lancet Diabetes & Endocrinology. The achievement offers hope to all countries worldwide battling the huge human and economic cost of type 2 diabetes.
The gold standard test
The prevalence of type 2 diabetes has been increasing globally for decades. Most countries do not conduct repeated, longitudinal diabetes surveys, and those that do rarely follow the standards recommended by the World Health Organisation: the 2-hour oral glucose tolerance test (OGTT).
In the OGTT, a person fasts for 8 to 10 hours, provides a fasting blood sample, then drinks a sweet liquid containing 75 grams of glucose. Additional blood samples are taken at one and two hours. Many studies rely on fasting plasma glucose or HbA1c tests instead, which have been shown to miss many asymptomatic cases that the OGTT can detect.
Mauritius is the only country in the world that has systematically used the OGTT to monitor type 2 diabetes and intermediate hyperglycemia over time.
Seven surveys over 34 years
The island nation, located in the Indian Ocean east of Madagascar with a population of 1.2 million, has undergone a profound socioeconomic transition, shifting its disease burden from infectious to chronic non-communicable diseases. Mauritius has monitored this transition through seven cross-sectional surveys conducted since 1987, initiated by Professor Paul Zimmet of Monash University, Melbourne.
The surveys were conducted by staff of the Ministry of Health and Wellness, with support from teams led by Prof. Zimmet, Prof. Jaakko Tuomilehto of the University of Helsinki, Prof. Sir George Alberti from the UK, and more recently Prof. Stefan Söderberg from Umeå, Sweden.
The numbers
The prevalence of type 2 diabetes in Mauritius across the seven surveys:
1. 1987: 14.7% overall (women 14.0%, men 15.3%)
2. 1992: 17.3% overall (women 16.6%, men 18.0%)
3. 1998: 20.2% overall (women 19.3%, men 21.1%)
4. 2004: 18.6% overall (women 18.3%, men 18.7%)
5. 2009: 23.3% overall (women 22.0%, men 24.7%)
6. 2015: 23.1% overall (women 23.7%, men 22.6%)
7. 2021: 19.9% overall (women 18.1%, men 21.7%)
Between 1987 and 2009, prevalence increased by 61% in men and 56% in women. But between 2009 and 2021, prevalence decreased by 11% in men and 16% in women, proving the epidemic can be reversed.
How Mauritius did it
The authors point to several multisectoral approaches that may explain the success:
1. Prevention: creating an action plan, policy including advocacy and legislation, NCD risk factor screening including mobile clinics, and community engagement through national action plans for nutrition, physical activity and tobacco control.
2. A national integrated NCD action plan: a roadmap to improve health and wellbeing across the life-course.
3. A national service framework for NCDs: defining standards of care within a service protocol with appropriate quality standards.
Public sector health services in Mauritius are free of charge, including essential medicines.
Source: News-Medical.net — "Mauritius becomes first country to reverse type 2 diabetes epidemic" (news-medical.net, UK). Research presented at EASD 2026 in Milan and published in The Lancet Diabetes & Endocrinology. The original article and image are © News-Medical.net.












